// our company

A Strong
Shareholder Base

eTheRNA’s shareholders are all highly renowned investors
in the life science sector.
Since its inception, eTheRNA has raised a total amount of over EUR 30 million in equity investments and non-dilutive funding, including
a Series A financing of EUR 24 million announced early 2016.
That was one of the largest private investment rounds for a start-up biotechnology company in Belgium, and even Europe.

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2020 Etherna | Studio Hanswijk